The patients with IBD often exhibit a decrease in IgA levels, which may impair the mucosal barrier function and contribute to the dysregulation of the gut microbiota (Bamias et al, 2023; Leake, 2014). The gene discussed is CD79A; the disease is inflammatory bowel disease.